Koyfin Home > Directory > Health Care > Akebia Therapeutics > Long-term Debt / Equity

Akebia Therapeutics Long-term Debt / Equity Chart (AKBA)

Akebia Therapeutics annual/quarterly Long-term Debt / Equity from 2014 to 2020.
  • Akebia Therapeutics Long-term Debt / Equity for the quarter ending June 06, 2020 was $27m a 77.46% increase of 21m year over year
  • Akebia Therapeutics Long-term Debt / Equity for the last 12 months ending June 06, 2020 was $27m a 77.46% increase of 21m year over year
Other Ratios Metrics:
  • Akebia Therapeutics Total Debt / Capital for the quarter ending December 12, 2018 was $2m a 99.29% increase of 2m year over year
  • Akebia Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $95m a 0.76% increase of 1m year over year
  • Akebia Therapeutics Total Debt / Equity for the quarter ending December 12, 2018 was $2m a 99.31% increase of 2m year over year
View Chart On Koyfin

Quarterly AKBA Long-term Debt / Equity Data

06/2020$27m
03/2020$26m
12/2019$26m
09/2019$6m
06/2019$6m
03/2019$6m
09/2017$0m
06/2017$0m
03/2017$0m
09/2016$0m

Annual AKBA Long-term Debt / Equity Data

2019$26m